FMOC-isocyclosporine A, a fluorescent labeled cyclosporine A, was encapsulated in solid lipid nanoparticles (SLN) prepared by the coacervation technique, and its anti-inflammatory activity was evaluated. The anti-inflammatory activity of the fluorescent labelled molecule, measured as inhibition of TNF-α secretion, is similar to the native one. SLN were compared to commercial formulations, through measurement of cytokine release and drug uptake in rat peripheral blood mononuclear cells. Drug-loaded SLN inhibit TNF-α secretion in a lower extent than commercial formulations, probably due to a lower uptake by the cells, but the increase of IL-10 secretion caused by the lipid matrix itself makes this formulation interesting for its anti-inflammatory activity.

Solid Lipid Nanoparticles Loaded with Fluorescent-labelled Cyclosporine A: Anti-inflammatory Activity in Vitro

GALLARATE, Marina;SERPE, Loredana;FOGLIETTA, FEDERICA;GIORDANO, SUSANNA MARZIA ADELE;PEIRA, Elena;CHIRIO, Daniela;BATTAGLIA, Luigi Sebastiano
2014-01-01

Abstract

FMOC-isocyclosporine A, a fluorescent labeled cyclosporine A, was encapsulated in solid lipid nanoparticles (SLN) prepared by the coacervation technique, and its anti-inflammatory activity was evaluated. The anti-inflammatory activity of the fluorescent labelled molecule, measured as inhibition of TNF-α secretion, is similar to the native one. SLN were compared to commercial formulations, through measurement of cytokine release and drug uptake in rat peripheral blood mononuclear cells. Drug-loaded SLN inhibit TNF-α secretion in a lower extent than commercial formulations, probably due to a lower uptake by the cells, but the increase of IL-10 secretion caused by the lipid matrix itself makes this formulation interesting for its anti-inflammatory activity.
2014
21
11
1157
1162
Coacervation, cyclosporine A, cytokines, FMOC, inflammation, solid lipid nanoparticles.
Gallarate, M.; Serpe, L.; Foglietta, F.; Giordano, S.; Peira, E.; Chirio, D.; Battaglia, L.
File in questo prodotto:
File Dimensione Formato  
Article revised_4aperto.pdf

Open Access dal 23/07/2015

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 116.49 kB
Formato Adobe PDF
116.49 kB Adobe PDF Visualizza/Apri
articolo ciclosporina-fmoc.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 1.15 MB
Formato Adobe PDF
1.15 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/155522
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact